Capital raised by Evofem Biosciences
2 Form D filings · first filed Apr 2025 · San Diego, CA
Chief Executive Officer
Signatory on Evofem Biosciences's Form D filings · $1.7M raised across 2
Saundra Pelletier is on file as Chief Executive Officer at Evofem Biosciences in San Diego, CA. Evofem Biosciences has 2 Form D filings on record, $1.7M raised in total. Saundra Pelletier appears as a signatory on the company's filings.
Phexxi is the first and only FDA-approved, hormone-free, on-demand contraceptive vaginal gel. Using a proprietary vaginal pH modulator, it is applied 0-60 minutes before intercourse to maintain a slightly acidic vaginal environment, which helps prevent sperm from fertilizing an egg.
